Characterization of CC-531 as a rat model of colorectal liver metastases

Sarah Beth White; Daniele Procissi; Jeane Chen; Venkateswara Rao Gogineni; Patrick Tyler; Yihe Yang; Reed A. Omary; Andrew C. Larson

doi:10.1371/journal.pone.0155334

Characterization of CC-531 as a rat model of colorectal liver metastases

Sarah Beth White, Daniele Procissi, Jeane Chen, Venkateswara Rao Gogineni, Patrick Tyler, Yihe Yang, Reed A. Omary, Andrew C. Larson

Radiology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Purpose: Surgical resection of colorectal liver metastases is not achievable in more than 70% of the cases. Although the liver directed therapies have become a part of the stand of care, lack of a preclinical model impedes the assessment of toxicity and therapeutic benefits attributed several candidate drugs or treatment regimens that can be designed. In the present study we aim develop and characterize a rat colorectal liver metastasis model. Materials and Methods: Growth characteristics of CC-531 cells were determined in vitro followed by subcapsular liver implantation in syngeneic WAG/Rij rats. Tumor growth progression was followed over 3 weeks by ultrasound (US) and magnetic resonance imaging (MRI). Growth characteristics were also assessed by histopathology and immunohistochemistry in harvested tumor tissues. Results: The doubling time of CC-531 cells was found be under 24hrs and all the implanted rats grew tumors. US imaging showed hypoechoic masses and MRI showed contrast enhancement representing complex tumor microenvironments. Hematoxylin and Eosin staining confirmed tumor growth and uniform CD31 staining in tumor confirmed even vessel density. Conclusion: CC-531 can be used as a metastatic rat tumor colorectal liver metastases model with well-defined characteristics that can be readily followed by imaging whilst having a therapeutic window for interventions.

Original language	English (US)
Article number	e0155334
Journal	PloS one
Volume	11
Issue number	5
DOIs	https://doi.org/10.1371/journal.pone.0155334
State	Published - May 1 2016

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Agricultural and Biological Sciences(all)
General

Access to Document

10.1371/journal.pone.0155334

Fingerprint Dive into the research topics of 'Characterization of CC-531 as a rat model of colorectal liver metastases'. Together they form a unique fingerprint.

Cite this

@article{df0a3cc13af74e61a606571114761f6d,

title = "Characterization of CC-531 as a rat model of colorectal liver metastases",

abstract = "Purpose: Surgical resection of colorectal liver metastases is not achievable in more than 70% of the cases. Although the liver directed therapies have become a part of the stand of care, lack of a preclinical model impedes the assessment of toxicity and therapeutic benefits attributed several candidate drugs or treatment regimens that can be designed. In the present study we aim develop and characterize a rat colorectal liver metastasis model. Materials and Methods: Growth characteristics of CC-531 cells were determined in vitro followed by subcapsular liver implantation in syngeneic WAG/Rij rats. Tumor growth progression was followed over 3 weeks by ultrasound (US) and magnetic resonance imaging (MRI). Growth characteristics were also assessed by histopathology and immunohistochemistry in harvested tumor tissues. Results: The doubling time of CC-531 cells was found be under 24hrs and all the implanted rats grew tumors. US imaging showed hypoechoic masses and MRI showed contrast enhancement representing complex tumor microenvironments. Hematoxylin and Eosin staining confirmed tumor growth and uniform CD31 staining in tumor confirmed even vessel density. Conclusion: CC-531 can be used as a metastatic rat tumor colorectal liver metastases model with well-defined characteristics that can be readily followed by imaging whilst having a therapeutic window for interventions.",

author = "White, {Sarah Beth} and Daniele Procissi and Jeane Chen and Gogineni, {Venkateswara Rao} and Patrick Tyler and Yihe Yang and Omary, {Reed A.} and Larson, {Andrew C.}",

note = "Funding Information: Histology was performed at Northwestern University Cell Imaging Facility generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. Dr. White received grant support from the Radiological Society of North America (RSNA RSD1342) and the NIH (R25CA132822-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Histology was performed at Northwestern University Cell Imaging Facility generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. MRI imaging was performed at the Center for Translational Imaging (CTI) at Northwestern University and the authors would like to acknowledge CTI for providing these resources for this study. Dr. White received grant support from the Radiological Society of North America (RSNA RSD1342) and the NIH (R25CA132822-03).",

year = "2016",

month = may,

day = "1",

doi = "10.1371/journal.pone.0155334",

language = "English (US)",

volume = "11",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "5",

}

TY - JOUR

T1 - Characterization of CC-531 as a rat model of colorectal liver metastases

AU - White, Sarah Beth

AU - Procissi, Daniele

AU - Chen, Jeane

AU - Gogineni, Venkateswara Rao

AU - Tyler, Patrick

AU - Yang, Yihe

AU - Omary, Reed A.

AU - Larson, Andrew C.

N1 - Funding Information: Histology was performed at Northwestern University Cell Imaging Facility generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. Dr. White received grant support from the Radiological Society of North America (RSNA RSD1342) and the NIH (R25CA132822-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Histology was performed at Northwestern University Cell Imaging Facility generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. MRI imaging was performed at the Center for Translational Imaging (CTI) at Northwestern University and the authors would like to acknowledge CTI for providing these resources for this study. Dr. White received grant support from the Radiological Society of North America (RSNA RSD1342) and the NIH (R25CA132822-03).

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose: Surgical resection of colorectal liver metastases is not achievable in more than 70% of the cases. Although the liver directed therapies have become a part of the stand of care, lack of a preclinical model impedes the assessment of toxicity and therapeutic benefits attributed several candidate drugs or treatment regimens that can be designed. In the present study we aim develop and characterize a rat colorectal liver metastasis model. Materials and Methods: Growth characteristics of CC-531 cells were determined in vitro followed by subcapsular liver implantation in syngeneic WAG/Rij rats. Tumor growth progression was followed over 3 weeks by ultrasound (US) and magnetic resonance imaging (MRI). Growth characteristics were also assessed by histopathology and immunohistochemistry in harvested tumor tissues. Results: The doubling time of CC-531 cells was found be under 24hrs and all the implanted rats grew tumors. US imaging showed hypoechoic masses and MRI showed contrast enhancement representing complex tumor microenvironments. Hematoxylin and Eosin staining confirmed tumor growth and uniform CD31 staining in tumor confirmed even vessel density. Conclusion: CC-531 can be used as a metastatic rat tumor colorectal liver metastases model with well-defined characteristics that can be readily followed by imaging whilst having a therapeutic window for interventions.

AB - Purpose: Surgical resection of colorectal liver metastases is not achievable in more than 70% of the cases. Although the liver directed therapies have become a part of the stand of care, lack of a preclinical model impedes the assessment of toxicity and therapeutic benefits attributed several candidate drugs or treatment regimens that can be designed. In the present study we aim develop and characterize a rat colorectal liver metastasis model. Materials and Methods: Growth characteristics of CC-531 cells were determined in vitro followed by subcapsular liver implantation in syngeneic WAG/Rij rats. Tumor growth progression was followed over 3 weeks by ultrasound (US) and magnetic resonance imaging (MRI). Growth characteristics were also assessed by histopathology and immunohistochemistry in harvested tumor tissues. Results: The doubling time of CC-531 cells was found be under 24hrs and all the implanted rats grew tumors. US imaging showed hypoechoic masses and MRI showed contrast enhancement representing complex tumor microenvironments. Hematoxylin and Eosin staining confirmed tumor growth and uniform CD31 staining in tumor confirmed even vessel density. Conclusion: CC-531 can be used as a metastatic rat tumor colorectal liver metastases model with well-defined characteristics that can be readily followed by imaging whilst having a therapeutic window for interventions.

UR - http://www.scopus.com/inward/record.url?scp=84969528718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969528718&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0155334

DO - 10.1371/journal.pone.0155334

M3 - Article

C2 - 27171151

AN - SCOPUS:84969528718

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e0155334

ER -